Parisi Gray Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.13M | Buy |
4,499
+32
| +0.7% | +$6.88K | 0.23% | 77 |
|
|
2026
Q1 | $972K | Buy |
4,467
+38
| +0.9% | +$8.43K | 0.23% | 73 |
|
|
2025
Q4 | $1.01M | Buy |
4,429
+34
| +0.8% | +$7.75K | 0.23% | 66 |
|
|
2025
Q3 | $1.02M | Buy |
4,395
+102
| +2% | +$20.8K | 0.26% | 64 |
|
|
2025
Q2 | $797K | Sell |
4,293
-60
| -1% | -$11.2K | 0.23% | 69 |
|
|
2025
Q1 | $912K | Buy |
4,353
+331
| +8% | +$64.3K | 0.3% | 59 |
|
|
2024
Q4 | $715K | Buy |
4,022
+261
| +7% | +$48K | 0.23% | 65 |
|
|
2024
Q3 | $743K | Buy |
3,761
+139
| +4% | +$25.9K | 0.25% | 64 |
|
|
2024
Q2 | $621K | Buy |
3,622
+278
| +8% | +$46K | 0.22% | 63 |
|
|
2024
Q1 | $609K | Buy |
3,344
+136
| +4% | +$23.4K | 0.23% | 67 |
|
|
2023
Q4 | $497K | Buy |
3,208
+32
| +1% | +$4.67K | 0.2% | 70 |
|
|
2023
Q3 | $473K | Buy |
3,176
+252
| +9% | +$37K | 0.22% | 69 |
|
|
2023
Q2 | $466K | Hold |
2,924
| – | – | 0.21% | 69 |
|
|
2023
Q1 | $466K | Buy |
2,924
+170
| +6% | +$26K | 0.29% | 54 |
|
|
2022
Q4 | $445K | Buy |
2,754
+56
| +2% | +$8.59K | 0.22% | 72 |
|
|
2022
Q3 | $362K | Buy |
2,698
+26
| +1% | +$3.73K | 0.28% | 60 |
|
|
2022
Q2 | $409K | Buy |
2,672
+25
| +0.9% | +$3.82K | 0.21% | 72 |
|
|
2022
Q1 | $429K | Sell |
2,647
-2
| -0.1% | -$291 | 0.17% | 85 |
|
|
2021
Q4 | $359K | Buy |
2,649
+92
| +4% | +$10.9K | 0.13% | 94 |
|
|
2021
Q3 | $279K | Buy |
2,557
+34
| +1% | +$3.88K | 0.12% | 106 |
|
|
2021
Q2 | $284K | Buy |
2,523
+28
| +1% | +$3.15K | 0.1% | 110 |
|
|
2021
Q1 | $270K | Buy |
2,495
+55
| +2% | +$5.88K | 0.11% | 107 |
|
|
2020
Q4 | $261K | Buy |
+2,440
| New | +$234K | 0.12% | 107 |
|
|
2020
Q3 | – | Sell |
-2,110
| Closed | -$207K | – | 117 |
|
|
2020
Q2 | $207K | Buy |
+2,110
| New | +$186K | 0.12% | 102 |
|
|
2019
Q2 | – | Sell |
-321
| Closed | -$26K | – | 106 |
|
|
2019
Q1 | $26K | Hold |
321
| – | – | 0.02% | 279 |
|
|
2018
Q4 | $29K | Hold |
321
| – | – | 0.02% | 270 |
|
|
2018
Q3 | $30K | Hold |
321
| – | – | 0.02% | 293 |
|
|
2018
Q2 | $31K | Sell |
321
-3
| -0.9% | -$293 | 0.02% | 293 |
|
|
2018
Q1 | $29K | Buy |
324
+3
| +0.9% | +$330 | 0.02% | 293 |
|
|
2017
Q4 | $32K | Buy |
+321
| New | +$30.3K | 0.02% | 276 |
|
Other funds holding ABBV
Parisi Gray Wealth Management's ABBV Position: Q2 2026 in Review
Parisi Gray Wealth Management increased its AbbVie (ABBV) stake by 0.72% in Q2 2026, buying an estimated $6.88K and bringing the position to 4,499 shares worth $1.13M. The position accounts for 0.23% of the portfolio, ranked #77.
Parisi Gray Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 30 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Parisi Gray Wealth Management held 4,499 shares of AbbVie worth $1.13M as of Q2 2026.
- Parisi Gray Wealth Management bought 32 AbbVie shares in Q2 2026, an estimated $6.88K.
- AbbVie made up 0.23% of Parisi Gray Wealth Management's portfolio in Q2 2026, its #77 holding.
- Parisi Gray Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 30 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Parisi Gray Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.